| LM ID |
Analyte |
Treatment |
Time(hrs) |
Sample ID |
Value |
Units |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
Lipid-depleted/compactin |
0.0 |
BCD100322A002 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
Lipid-depleted/compactin |
0.5 |
BCD100322A005 |
0.62 |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
Lipid-depleted/compactin |
1.0 |
BCD100322A009 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
Lipid-depleted/compactin |
2.0 |
BCD100322A013 |
1.24 |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
Lipid-depleted/compactin |
4.0 |
BCD100322A017 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
Lipid-depleted/compactin |
8.0 |
BCD100322A021 |
2.9 |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
Lipid-depleted/compactin |
12.0 |
BCD100322A025 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
Lipid-depleted/compactin |
24.0 |
BCD100322A029 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
C |
0.0 |
BCD100322A001 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
C |
0.5 |
BCD100322A003 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
C |
1.0 |
BCD100322A007 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
C |
2.0 |
BCD100322A011 |
1.1 |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
C |
4.0 |
BCD100322A015 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
C |
8.0 |
BCD100322A019 |
0.61 |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
C |
12.0 |
BCD100322A023 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
C |
24.0 |
BCD100322A027 |
1.57 |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
0.5 |
BCD100322A006 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
1.0 |
BCD100322A010 |
0.49 |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
2.0 |
BCD100322A014 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
4.0 |
BCD100322A018 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
8.0 |
BCD100322A022 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
12.0 |
BCD100322A026 |
3.66 |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
24.0 |
BCD100322A030 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol |
0.5 |
BCD100322A004 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol |
1.0 |
BCD100322A008 |
0.85 |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol |
2.0 |
BCD100322A012 |
- |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol |
4.0 |
BCD100322A016 |
2.4 |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol |
8.0 |
BCD100322A020 |
0.14 |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol |
12.0 |
BCD100322A024 |
0.28 |
pmol/sample |
| LMFA01030157 |
5,8,11-eicosatrienoic acid |
25OH-Chol |
24.0 |
BCD100322A028 |
- |
pmol/sample |